QUINOLONE ANALOGUES AND RELATED METHODS Russian patent published in 2015 - IPC C07D471/14 C07D513/14 A61K31/4375 A61K31/444 A61K31/4545 A61K31/496 A61K31/497 A61K31/551 A61K31/5377 A61P31/00 A61P35/00 

Abstract RU 2549895 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a compound of formula , wherein A and V independently represents H or a halogen; Q is absent; R4 independently represents H, a C1-C6 alkyl or C3-C6 cycloalkyl; R7 represents H; and R8 represents a C1-C10 alkyl substituted by OH or C1-C6 alkoxy; or C1-4 alkyl substituted by a 5-6-merous aromatic heterocyclic ring containing 1-2 heteroatoms specified in N and S, wherein the above aromatic heterocyclic ring is optionally substituted by a C1-C10 alkyl; or in -NR7R8, R7 and R8 together with N can form an optionally substituted azacyclic ring containing where applicable an additional heteroatom specified in H, O and S, as a cycle member, optionally substituted by a C1-C10 alkyl, which is substituted by a C1-C6 alkoxy; m is equal to 0; n is equal to 0. The invention also refers to a compound of formula (wherein the substitutes are those as specified in the patient claim), to a pharmaceutical composition containing a therapeutically effective amount of the compounds of formula (VIII), and to a method of treating or relieving a cell-proliferative disorder.

EFFECT: compound of formula (VIII) inhibiting cell proliferation or cell apoptosis.

12 cl, 1 dwg, 14 tbl, 55 ex

Similar patents RU2549895C2

Title Year Author Number
SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS 2013
  • Chua Piter K.
  • Per Fabris
  • Vitten Dzheffri P.
RU2681209C2
COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT 2016
  • Sung Dzhon
RU2752506C2
COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER 2016
  • Sung, Dzhon
RU2786570C2
METHODS FOR SELECTIVE INTRODUCTION OF PROTECTIVE GROUPS INTO RESORCINOL DERIVATIVES 2019
  • Chupakhin Oleg Nikolaevich
  • Fatykhov Ramil Faatovich
  • Inyutina Anna Konstantinovna
  • Khalymbadzha Igor Alekseevich
RU2738408C1
INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF 2015
  • Gen Mejyu
  • Lyu Lej
  • Tszyan Lej
  • Khuan Min
  • Chzha Chuantao
  • Aj Tszin
  • Van Lej
  • Tsao Tszyankhua
  • Din Tszyan
RU2719428C2
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES 2006
  • Lissikatos Dzhozef P.
  • Marmsater Fredrik P.
  • Chao Chzhan'
  • Greschuk Dzhuli Mari
  • Vejdong L'Ju
  • Khennings Dehvid D.
RU2428421C2
APPLICATION OF ARYL AND HETARYL CARBOXAMIDES AS ENDOPARASITICIDES 2012
  • Shvarts Khans-Georg
  • Trautvajn Aksel
  • Vilims Lotar
  • Khink Majke
  • Lyummen Peter
  • Gergens Ulrikh
  • Kokeron Per-Iv
  • Kharder Akhim
  • Velts Klaudia
  • Grojl Jorg
RU2638830C2
HETEROBICYCLIC HEPATITIS C VIRUS (HCV) INHIBITORS 2006
  • Simmen Kennet Alan
  • Chakravarti Sarvadzhit
  • Khart Barri
  • Sjurlero Dominik Lui Nestor Gilehjn
  • Lin' Tsze-I
  • Lents Oliver
  • Rabuasson P'Er Zhan-Mari Bernar
RU2405783C2
BICYCLIC AGONISTS OF STING INTERFERON GENE STIMULATOR 2020
  • Petrassi, Khenk Majkl Dzhejms
  • Yuj, Chenian
  • Van, Tsze
  • Chatterdzhi, Arnab K.
  • Albero, Ana Mariya Gamo
  • Gupta, Anil
  • Tamijya, Dzhanko
  • Shults, Piter Dzh.
  • Dzhonson, Kristen
  • Chu, Alan
  • Chin, Emili
  • Lejrson, Lyuk L.
RU2813691C2
BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING 2020
  • Petrassi, Khenk Majkl Dzhejms
  • Yuj, Chenian
  • Van, Tsze
  • Chatterdzhi, Arnab K.
  • Shults, Piter Dzh.
  • Dzhonson, Kristen
  • Chu, Alan
  • Chin, Emili
  • Lejrson, Lyuk L.
RU2800072C1

RU 2 549 895 C2

Authors

Nagasava Dzhonni Jasuo

P'Er Fabris

Khaddakh Mustafa

Shvebe Majkl

Dardzhanija Levan

Vitten Dzheffri P.

Dates

2015-05-10Published

2008-10-03Filed